- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06150105
Changes in the Hormonal and Inflammatory Profile of Young Sprint- and Endurance-trained Athletes. (CHIPYA)
Changes in the Hormonal and Inflammatory Profile of Young Sprint- and Endurance-trained Athletes Following a Sports Camp
One essential element of athlete training is conditioning camps, where athletes undergo a rigorous and targeted training schedule to prepare for upcoming sporting events. During sports camps, due to the accumulation of a large number of training units, including high-intensity exercises, athletes react with post-exercise overload, acute fatigue, and overreaching which can become a chronic overtraining syndrome. Overtraining syndrome is a very specific and severe condition where overtraining without adequate rest and recovery leads to performance decrements lasting more than 2-3 months, coupled with a mood disturbance. The exact etiology and pathogenesis are unknown and actively being investigated.
During training camps the balance between training volumes and recovery is often a delicate one and, the accumulation of exercise-induced stress may exceed the capacity of both neuroendocrine and immune adaptation leading to an alteration of physiological functions, decreasing adaptation to performance, impairment of psychological processing, immunological dysfunction, and biochemical abnormalities. Moreover, there is currently a lack of biomarkers accessible to assist in diagnosing and, what's even more important - help to prevent the overtraining syndrome, except for the continued presence of unexplained underperformance despite athletes' adequate rest and recovery.
Thus, this study aims to explain how long and intensive training for endurance affects the hormonal and immune systems of young athletes.
The main questions it aims to answer are:
- How does intense training influence hormonal and immune responses in young, trained athletes?
- Does training specialization affect the hormonal and immune response to intense training?
Study Overview
Detailed Description
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Poznań, Poland, 61-871
- Poznań University of Physical Education
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- age 15-17 years,
- minimum of 3 years of training experience,
- specialization in anaerobic and aerobic disciplines.
Exclusion Criteria:
- presence of acute or chronic inflammation
- fever, infections, injuries
- se of any anti-inflammatory drugs.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
sprint-trained
Sprint-trained athletes: 6 male and 6 female, aged average 15 y.,
|
Intense endurance training
|
|
endurance-trained
Endurance-trained athletes: 6 male and 6 female, aged average 15 y.,
|
Intense endurance training
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in epinephrine serum level.
Time Frame: at rest baseline (before training), after 4 - and after another 5 days of training.
|
marker of HPA axis functioning, stress hormone.
|
at rest baseline (before training), after 4 - and after another 5 days of training.
|
|
Changes in norepinephrine serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
|
marker of HPA axis functioning, stress hormone.
|
at rested baseline (before training), after 4 - and after another 5 days of training.
|
|
Changes in cortisol serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
|
marker of HPA axis functioning, stress hormone
|
at rested baseline (before training), after 4 - and after another 5 days of training.
|
|
Changes in hs-CRP serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
|
marker of inflammatory response.
|
at rested baseline (before training), after 4 - and after another 5 days of training.
|
|
Changes in Myoglobin serum level.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
|
marker of muscle damage
|
at rested baseline (before training), after 4 - and after another 5 days of training.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in blood morphology.
Time Frame: sat rested baseline (before training), after 4 - and after another 5 days of training.
|
Morphometric measurements of blood cell.
|
sat rested baseline (before training), after 4 - and after another 5 days of training.
|
|
Changes in epinephrine/norepinephrine ratio.
Time Frame: at rested baseline (before training), after 4 - and after another 5 days of training.
|
marker of responsiveness of the adrenal medulla to sympathetic nervous activity.
|
at rested baseline (before training), after 4 - and after another 5 days of training.
|
Collaborators and Investigators
Investigators
- Principal Investigator: Joanna Ostapiuk-Karolczuk, Ph.D., Poznań University of Physical Education
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 530/18
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overtraining Syndrome
-
University of ThessalyUnknown
-
University of Novi Sad, Faculty of Sport and Physical...Completed
-
Charite University, Berlin, GermanyGerman Sport University, CologneEnrolling by invitationMuscle Atrophy | Myotonia | Stiffness; Spine | Exercise OvertrainingGermany
-
Indonesia UniversityCompletedSports Physical Therapy | Military Activity | Exercise OvertrainingIndonesia
-
KTO Karatay UniversityRecruiting
-
National Yang Ming UniversityRecruitingStressor, Psychological | Exercise OvertrainingTaiwan
-
Association Tunisienne d'Etude & de Recherche sur...RecruitingObesity | Cardiometabolic Syndrome | Exercise Overtraining | EnjoymentTunisia
-
Ankara UniversityCompleted
-
King Saud UniversityCompletedOsteoporosis | Exercise Overtraining | Vitamin D 25-Hydroxylase Deficiency
Clinical Trials on Exercise training
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São PauloCompleted
-
University of British ColumbiaMichael Smith Foundation for Health ResearchCompleted
-
Universidade Norte do ParanáCompleted
-
University of Colorado, DenverVA Eastern Colorado Health Care SystemCompletedHealthy | Overweight | Type 2 Diabetes Mellitus | Cardiovascular Risk FactorUnited States
-
National Taiwan University HospitalCompletedAtrial FibrillationTaiwan
-
Universita di VeronaRecruiting
-
University of LeipzigCompletedImpact of Intensive Exercise Training on Coronary Collateral Circulation in Patients With Stable CADStable Coronary Artery DiseaseGermany
-
Helse Stavanger HFStavanger Health ResearchCompletedVentricular TachycardiaNorway
-
Hacettepe UniversityCompleted
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada